ARRY : Analysis & Opinions

  1. Array Announces $100M Public Offering (ARRY)

    September 29, 2016
    Array BioPharma is looking to raise around $100 million in capital by offering its shares for sale through a public offer.
  2. Array BioPharma Reports Positive Results (ARRY)

    September 28, 2016
    Positive top-line data is paving the way for the company to apply for global regulatory approvals.
  3. Array Secures SPA Agreement With FDA for Colorectal Cancer Trial ...

    September 14, 2016
    With an SPA agreement with the FDA, Array’s phase III trial could lead it to be the first company to offer treatment of BRAF-mutant ...
  4. Why Array Biopharma May Become a Winner (ARRY)

    September 12, 2016
    Array Biopharma is making rapid progress on two drugs treating cardiovascular disease and cancer. The good news: it faces ...
  5. How To Approach Momentum Trading Like A Pro

    February 18, 2015
    Momentum markets generate high-reward high-risk environments that confound traders until they employ specific risk management ...